Conexeu Sciences Inc (CNXU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,023 | -1,719 | N/A | -748 | -290 |
| Depreciation Amortization | 18 | 6 | N/A | 4 | 1 |
| Other Working Capital | 168 | -13 | N/A | 32 | 4 |
| Other Operating Activity | 497 | 189 | 0 | 48 | 50 |
| Operating Cash Flow | $-3,340 | $-1,536 | $N/A | $-665 | $-236 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -5 | N/A | -18 | -14 |
| Investing Cash Flow | $-35 | $-5 | $N/A | $-18 | $-14 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -98 | N/A |
| Common Stock Issued | 2,943 | 1,005 | N/A | 550 | 550 |
| Dividend Paid | N/A | N/A | N/A | -4 | N/A |
| Other Financing Activity | 2,900 | 2,411 | 0 | 0 | 0 |
| Financing Cash Flow | $5,843 | $3,416 | $N/A | $448 | $550 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -3 |
| Beginning Cash Position | 4,834 | 4,834 | N/A | 315 | 315 |
| End Cash Position | 7,302 | 6,709 | N/A | 79 | 612 |
| Net Cash Flow | $2,468 | $1,875 | $N/A | $-235 | $301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,340 | -1,536 | N/A | -665 | -236 |
| Capital Expenditure | -35 | -5 | N/A | -18 | -14 |
| Free Cash Flow | -3,375 | -1,541 | 0 | -683 | -249 |